The Brief
What Qure.ai Chest does and why it matters
Qure.ai provides FDA-cleared AI for analyzing chest X-rays to detect tuberculosis, pneumonia, and lung abnormalities. Used extensively in low-resource settings to extend radiologist capacity in high-burden disease areas.
Builder’s Brief
Qure.ai Chest is a healthcare tool on Falcoscan. AI chest X-ray analysis for tuberculosis and pneumonia. Falcoscan rates Qure.ai Chest with an Opportunity score of 86/100, a Saturation score of 8/100, and a Wrapper-risk score of 11/100. Market signal: hot. Qure.ai Chest is founded in 2016, currently at Series_a stage. Pricing: Paid. Rating 4.6/5 across 11 tracked views.